 SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 24, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 